Clinical Pearls: Providing a Timely Diagnosis of Endometriosis and Effective Management of Endometriosis-Associated Pain
Released On
December 22, 2023
Expires On
October 13, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Endometriosis, Obstetrics, Gynecology, Reproductive Sciences
Topic(s)
Endometriosis, Obstetrics, Gynecology, Reproductive Sciences
This activity is provided by Med Learning Group.
This activity is co-provided by AMEDCO.
Nursing learners, view this Learner Notification prior to starting this activity
This activity is supported by educational grants from Pfizer and Myovant Sciences, Inc.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — maximum of 1.0 ANCC contact hour
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is intended for US-based obstetrician-gynecologists and other healthcare professionals involved in the care and treatment of patients with endometriosis.
Program Overview
This enduring educational activity will help obstetrician-gynecologists and other healthcare professionals better design strategies to facilitate an earlier clinical diagnosis of endometriosis. Additionally, these activities aim to have healthcare professionals assess the benefits associated with the use of medical therapies early in the patient treatment journey and in conjunction with surgery. Ultimately, HCPs should leave this program able to develop treatment plans for the long-term management of endometriosis-associated pain based on results from clinical trials supporting the efficacy and safety of available therapies.
Educational Objectives
Upon the completion of this program, attendees should be able to:
- Design strategies aimed at facilitating an earlier clinical diagnosis of endometriosis
- Assess the benefits associated with the use of medical therapies early in the patient treatment journey and in conjunction with surgery
- Develop treatment plans for the long-term management of endometriosis-associated pain based on results from clinical trials supporting the efficacy and safety of available therapies
Faculty
Hugh S. Taylor, MD
PROGRAM CHAIR & FACULTY PRESENTER
Anita O'Keeffe Young Professor and Chair
Department of Obstetrics, Gynecology, and Reproductive Sciences
Yale School of Medicine
Chief of Obstetrics and Gynecology
Yale-New Haven Hospital
New Haven, CT
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Relationship(s)
- Hugh S. Taylor, MD
- Consultant: Fortress Biotech
- Grant Recipient: AbbVie
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Cindy Lampner, MSLIS, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
Aimee Meissner, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Lauren Bartunek, Program Manager for Med Learning Group, has nothing to disclose.
Heather Gee, Program Coordinator for Med Learning Group, has nothing to disclose.
Method of Participation
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Content - Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
